Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply

被引：0
|
作者：
Zhao, Jianhui [1 ,2 ]
Xue, Erxu [3 ]
Liu, Zhanju [4 ,5 ]
Li, Xue [1 ,2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Big Data Hlth Sci, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Nursing Dept, Hangzhou, Zhejiang, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Inflammatory Bowel Dis Res, Shanghai, Peoples R China
[5] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/apt.18414
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [41] Letter: Allostatic load and adverse prognosis in inflammatory bowel disease-Need more evidence
    Xu, Lingyu
    Guan, Chen
    Zhao, Long
    Xu, Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1483 - 1484
  • [42] Thrombophilia and inflammatory bowel disease.
    Heneghan, MA
    Cleary, B
    Murray, M
    OGorman, TA
    McCarthy, CF
    GASTROENTEROLOGY, 1997, 112 (04) : A994 - A994
  • [43] Nutrition in inflammatory bowel disease.
    Kelly D.G.
    Current Gastroenterology Reports, 1999, 1 (4) : 324 - 330
  • [44] Arthritis and inflammatory bowel disease.
    Wordsworth P.
    Current Rheumatology Reports, 2000, 2 (2) : 87 - 88
  • [45] Methotrexate in inflammatory bowel disease.
    Blasco, D
    Valriberas, G
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1997, 89 (05) : 385 - 390
  • [46] Cyclosporine in inflammatory bowel disease.
    Kornbluth A.
    Current Gastroenterology Reports, 1999, 1 (6) : 486 - 490
  • [47] Corticosteroids in inflammatory bowel disease.
    Modigliani, R
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (5BIS): : B169 - B177
  • [48] Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply
    Ahmed, I.
    Greenwood, R.
    Costello, B.
    Ratcliffe, N.
    Probert, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1241 - 1242
  • [49] Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply
    Lee, Kate E.
    Faye, Adam S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (07) : 1213 - 1214
  • [50] Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease: authors' reply
    Jakobsen, C.
    Bartek, J., Jr.
    Wewer, V.
    Vind, I.
    Munkholm, P.
    Groen, R.
    Paerregaard, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) : 392 - 393
12345